Immunohistochemical and FISH analysis of EGFR and its prognostic value in patients with oral squamous cell carcinoma

Standard

Immunohistochemical and FISH analysis of EGFR and its prognostic value in patients with oral squamous cell carcinoma. / Gröbe, Alexander; Eichhorn, Wolfgang; Fraederich, Meike; Kluwe, Lan; Vashist, Yogesh; Wikner, Johannes; Smeets, Ralf; Simon, Ronald; Sauter, Guido; Heiland, Max; Blessmann, Marco.

In: J ORAL PATHOL MED, Vol. 43, No. 3, 2014, p. 205-10.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

APA

Vancouver

Bibtex

@article{2e184ccfaebd4b388428e1040aba0046,
title = "Immunohistochemical and FISH analysis of EGFR and its prognostic value in patients with oral squamous cell carcinoma",
abstract = "OBJECTIVES: To study immunohistochemical expression of the epithelial growth factor receptor (EGFR) in oral carcinomas and the head and neck region to examine possible associations with various features of the tumors and survival of the patients.MATERIALS AND METHODS: Sections were made from two tissue arrays composed of 206 oral squamous cell carcinomas and 427 squamous cell carcinomas of the head and neck region, respectively, and examined for EGFR expression and Ki-67 labeling index by means of immunohistochemistry, and for EGFR gene amplification by means of fluorescence in situ hybridization. Correlation between resulting parameters and with clinical features was evaluated using chi-square test and Kaplan-Meyer analysis.RESULTS: A statistically significant association was observed for strong EGFR immunohistochemical (IHC) expression with advanced lymph node involvement (P = 0.02). EGFR immunohistochemical expression did not significantly correlate with patient disease specific (DS) or overall survival (OS). EGFR gene amplification was not correlated with any of the tumor features nor to survival of the patients (DS and OS).DISCUSSION: Epithelial growth factor receptor IHC expression and gene amplification might be suitable to predict locoregional control in oral squamous cell carcinoma patients but an inappropriate predictor for patients survival.",
author = "Alexander Gr{\"o}be and Wolfgang Eichhorn and Meike Fraederich and Lan Kluwe and Yogesh Vashist and Johannes Wikner and Ralf Smeets and Ronald Simon and Guido Sauter and Max Heiland and Marco Blessmann",
note = "{\textcopyright} 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.",
year = "2014",
doi = "10.1111/jop.12111",
language = "English",
volume = "43",
pages = "205--10",
journal = "J ORAL PATHOL MED",
issn = "0904-2512",
publisher = "Wiley-Blackwell",
number = "3",

}

RIS

TY - JOUR

T1 - Immunohistochemical and FISH analysis of EGFR and its prognostic value in patients with oral squamous cell carcinoma

AU - Gröbe, Alexander

AU - Eichhorn, Wolfgang

AU - Fraederich, Meike

AU - Kluwe, Lan

AU - Vashist, Yogesh

AU - Wikner, Johannes

AU - Smeets, Ralf

AU - Simon, Ronald

AU - Sauter, Guido

AU - Heiland, Max

AU - Blessmann, Marco

N1 - © 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

PY - 2014

Y1 - 2014

N2 - OBJECTIVES: To study immunohistochemical expression of the epithelial growth factor receptor (EGFR) in oral carcinomas and the head and neck region to examine possible associations with various features of the tumors and survival of the patients.MATERIALS AND METHODS: Sections were made from two tissue arrays composed of 206 oral squamous cell carcinomas and 427 squamous cell carcinomas of the head and neck region, respectively, and examined for EGFR expression and Ki-67 labeling index by means of immunohistochemistry, and for EGFR gene amplification by means of fluorescence in situ hybridization. Correlation between resulting parameters and with clinical features was evaluated using chi-square test and Kaplan-Meyer analysis.RESULTS: A statistically significant association was observed for strong EGFR immunohistochemical (IHC) expression with advanced lymph node involvement (P = 0.02). EGFR immunohistochemical expression did not significantly correlate with patient disease specific (DS) or overall survival (OS). EGFR gene amplification was not correlated with any of the tumor features nor to survival of the patients (DS and OS).DISCUSSION: Epithelial growth factor receptor IHC expression and gene amplification might be suitable to predict locoregional control in oral squamous cell carcinoma patients but an inappropriate predictor for patients survival.

AB - OBJECTIVES: To study immunohistochemical expression of the epithelial growth factor receptor (EGFR) in oral carcinomas and the head and neck region to examine possible associations with various features of the tumors and survival of the patients.MATERIALS AND METHODS: Sections were made from two tissue arrays composed of 206 oral squamous cell carcinomas and 427 squamous cell carcinomas of the head and neck region, respectively, and examined for EGFR expression and Ki-67 labeling index by means of immunohistochemistry, and for EGFR gene amplification by means of fluorescence in situ hybridization. Correlation between resulting parameters and with clinical features was evaluated using chi-square test and Kaplan-Meyer analysis.RESULTS: A statistically significant association was observed for strong EGFR immunohistochemical (IHC) expression with advanced lymph node involvement (P = 0.02). EGFR immunohistochemical expression did not significantly correlate with patient disease specific (DS) or overall survival (OS). EGFR gene amplification was not correlated with any of the tumor features nor to survival of the patients (DS and OS).DISCUSSION: Epithelial growth factor receptor IHC expression and gene amplification might be suitable to predict locoregional control in oral squamous cell carcinoma patients but an inappropriate predictor for patients survival.

U2 - 10.1111/jop.12111

DO - 10.1111/jop.12111

M3 - SCORING: Journal article

C2 - 24020871

VL - 43

SP - 205

EP - 210

JO - J ORAL PATHOL MED

JF - J ORAL PATHOL MED

SN - 0904-2512

IS - 3

ER -